![Peter W. Letebdre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter W.
Letendre joined Replidyne, Inc. in March 2005 as Chief Commercial Officer.
He held various commercial positions at SmithKline Beecham, GlaxoSmithKline and Abbott Laboratories.
Dr. Letendre was Vice President and General Manager of the Anti-Infective Franchise for Abbott Laboratories.
He was Marketing Director of Diabetes Franchise for SmithKline Beecham and GlaxoSmithKline from 2000 to 2002 and Marketing Director of Augmentin® and Timentin from 2000 to 2002.
Dr. Letendre was Product Manager and Senior Product Manager of Paxil, Requip and Bactroban and an Associate Dean of Clinical Practice at Southeastern University of the Health Sciences.
He received a BS degree and a Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Allied Health Sciences.
| Sociétés | Poste | Fin |
|---|---|---|
Replidyne, Inc.
 Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
